{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:51:35Z","timestamp":1791445895397,"version":"4.3.3"},"reference-count":20,"publisher":"Oceanside Publications Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"Background:<\/jats:bold> Inhaled corticosteroids (ICS) are widely prescribed medications. Some studies have reported that ICS may suppress the hypothalamic-pituitary-adrenal axis and induce systemic effects. Objective:<\/jats:bold> To explore the possibility of a dose-dependent\n association between the long-term use of ICS and the risk of obesity and other markers of metabolic syndrome. Methods:<\/jats:bold> A 5-year retrospective two-arm cohort study explored patients on asthma and not on ICS relative to patients with asthma who were on varying doses of ICS\n (low, medium, and high) and attributes such as body mass index (BMI) trajectory and prescription of antihypertensive, antidiabetic, and cholesterol-lowering medications. Results:<\/jats:bold> A total of 229 subjects with asthma were in the control cohort, and 215 subjects with asthma\n were in the ICS cohort. The ICS cohort was subdivided into individuals on low- (n = 88), medium- (n = 107), or high- (n = 20) dose ICS throughout the 5-year study period. For every 1-year increase in time, the BMI in the high-dose ICS group increased at a rate of 0.25 kg\/m2<\/jats:sup> when\n compared with the subjects in the control group after controlling for age and gender. Also, for every 1-year increase in time, the BMI of those on medium-dose ICS increased by 0.06 kg\/m2<\/jats:sup> compared with those in the control group after controlling for age and gender. The subjects\n on ICS also had a statistically increased risk of being prescribed antihypertensive, antidiabetic, and cholesterol-lowering medications. Conclusion:<\/jats:bold> ICS use in the subjects with asthma was associated with a dose-dependent risk of increasing BMI trajectories over time and\n an increased requirement for antidiabetic and cholesterol-lowering medications. One possible conclusion from this study is that long-term medium- and high-dose ICS have the potential to induce systemic effects.<\/jats:p>","DOI":"10.2500\/aap.2022.43.220027","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T04:31:22Z","timestamp":1662438682000},"page":"446-453","source":"Crossref","is-referenced-by-count":16,"title":["Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma"],"prefix":"10.2500","volume":"43","author":[{"given":"Hannah","family":"Wangberg","sequence":"first","affiliation":[{"name":"From the Department of Allergy, Asthma, and Immunology, Scripps Health, San Diego, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diba","family":"Mortazavi","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, University of California San Diego and Rady Children's Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kitsen","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, University of California San Diego and Rady Children's Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adepeju","family":"Sanni","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, University of California San Diego and Rady Children's Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Leibel","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, University of California San Diego and Rady Children's Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, University of California San Diego and Rady Children's Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","first-page":"CD009471","article-title":"Inhaled corticosteroids in children with persistent asthma: effects on growth","volume":"2014","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","article-title":"Use of inhaled corticosteroids and the risk of cataracts","volume":"337","author":"Cumming","year":"1997","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000501617","article-title":"Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders","volume":"110","author":"Savas","year":"2020","journal-title":"Neuroendocrinology"},{"key":"B5","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/jc.2017-01133","article-title":"Associations between systemic and local corticosteroid use with metabolic syndrome and body mass index","volume":"102","author":"Savas","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","first-page":"128","article-title":"Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate","volume":"30","author":"Packe","year":"1996","journal-title":"J R Coll Physicians Lond"},{"key":"B7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/02770903.2018.1455853","article-title":"Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma","volume":"56","author":"Han","year":"2019","journal-title":"J Asthma"},{"key":"B8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1164\/rccm.202009-3537OC","article-title":"Associations between inhaled corticosteroid use in the first 6 years of life and obesity-related traits","volume":"204","author":"Kun\u00f8e","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/thx.52.1.55","article-title":"Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients","volume":"52","author":"Clark","year":"1997","journal-title":"Thorax"},{"key":"B10","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1940-6207.CAPR-11-0218","article-title":"Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study","volume":"4","author":"Aleksandrova","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/pcan.2017.1","article-title":"Meta-analysis of metabolic syndrome and prostate cancer","volume":"20","author":"Gacci","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fonc.2019.01290","article-title":"Association between metabolic syndrome and breast cancer risk: an updated meta-analysis of follow-up studies","volume":"9","author":"Guo","year":"2019","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/met.2008.0070","article-title":"Health care utilization and costs by metabolic syndrome risk factors","volume":"7","author":"Boudreau","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/1535370214525302","article-title":"Obesity and asthma: pathophysiology and implications for diagnosis and management in primary care","volume":"239","author":"Mohanan","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"B19","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.2500\/aap.2021.42.210020","article-title":"Association between elevated serum triglycerides and asthma in patients with obesity: an explorative study","volume":"42","author":"van Zelst","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B20","article-title":"Global Initiative for Asthma-Pocket Guide for Professionals","author":"Pedersen","year":"2018","journal-title":"GINA Main Pocket Guide 2018 v1.0"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2022\/00000043\/00000005\/art00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:35:31Z","timestamp":1742358931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2022.43.220027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9,1]]}},"alternative-id":["1088-5412(20220901)43:5L.446;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2022.43.220027","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}